1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Veverka, V.
Cheng, X.
Waters, L.C.
Muskett, F.W.
Morgan, S.
Lesley, A.
Griffiths, M.
Stubberfield, C.
Griffin, R.
Henry, A.J.
Robinson, M.K.
Jansson, A.
Ladbury, J.E.
Ikemizu, S.
Davis, S.J.
Carr, M.D.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
288
11771
11785
10.1074/jbc.M112.448126
23417675
Structure and interactions of the human programmed cell death 1 receptor.
2013
13245.809
Programmed cell death protein 1
1
man
polymer
Protein PD-1, hPD-1
no
no
MPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDSRFRVTQLPNGRDFHMSVVR
ARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAE
MPPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDSRFRVTQLPNGRDFHMSVVR
ARRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
sample
PDCD1, PD1
9606
Homo sapiens
562
Escherichia coli
plasmid
pET
repository
Initial release
Database references
Database references
1
0
2013-02-27
1
1
2013-03-06
1
2
2013-05-15
BMRB
Y
RCSB
2012-12-18
REL
REL
REL
structures with the least restraint violations
100
35
2D 1H-15N HSQC
2D 1H-13C HSQC
2D 1H-1H TOCSY
2D 1H-1H NOESY
3D HNCACB
3D CBCA(CO)NH
3D HNCO
3D HCCH-TOCSY
3D 1H-15N TOCSY
3D 1H-13C NOESY
3D 1H-15N NOESY
0.5
mM
[U-15N]
25
mM
100
mM
0.5
mM
[U-13C; U-15N]
25
mM
100
mM
0.5
mM
25
mM
100
mM
0.125
6.4
ambient
298
K
DGSA-distance geometry simulated annealing
1
closest to the average
0.5 mM [U-15N] protein, 25 mM potassium phosphate, 100 mM sodium chloride, 95% H2O/5% D2O
95% H2O/5% D2O
0.5 mM [U-13C; U-15N] protein, 25 mM potassium phosphate, 100 mM sodium chloride, 95% H2O/5% D2O
95% H2O/5% D2O
0.5 mM protein, 25 mM potassium phosphate, 100 mM sodium chloride, 100% D2O
100% D2O
Bruker Biospin
collection
TOPSPIN
Goddard
data analysis
SPARKY
Guntert, Mumenthaler and Wuthrich
structure solution
CYANA
Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollman
structure solution
AMBER
Case, Darden, Cheatham, III, Simmerling, Wang, Duke, Luo, ... and Kollman
refinement
AMBER
600
Bruker
Avance
Bruker Avance
800
Bruker
Avance
Bruker Avance
MET
33
n
1
MET
33
A
PRO
34
n
2
PRO
34
A
PRO
35
n
3
PRO
35
A
THR
36
n
4
THR
36
A
PHE
37
n
5
PHE
37
A
SER
38
n
6
SER
38
A
PRO
39
n
7
PRO
39
A
ALA
40
n
8
ALA
40
A
LEU
41
n
9
LEU
41
A
LEU
42
n
10
LEU
42
A
VAL
43
n
11
VAL
43
A
VAL
44
n
12
VAL
44
A
THR
45
n
13
THR
45
A
GLU
46
n
14
GLU
46
A
GLY
47
n
15
GLY
47
A
ASP
48
n
16
ASP
48
A
ASN
49
n
17
ASN
49
A
ALA
50
n
18
ALA
50
A
THR
51
n
19
THR
51
A
PHE
52
n
20
PHE
52
A
THR
53
n
21
THR
53
A
CYS
54
n
22
CYS
54
A
SER
55
n
23
SER
55
A
PHE
56
n
24
PHE
56
A
SER
57
n
25
SER
57
A
ASN
58
n
26
ASN
58
A
THR
59
n
27
THR
59
A
SER
60
n
28
SER
60
A
GLU
61
n
29
GLU
61
A
SER
62
n
30
SER
62
A
PHE
63
n
31
PHE
63
A
VAL
64
n
32
VAL
64
A
LEU
65
n
33
LEU
65
A
ASN
66
n
34
ASN
66
A
TRP
67
n
35
TRP
67
A
TYR
68
n
36
TYR
68
A
ARG
69
n
37
ARG
69
A
MET
70
n
38
MET
70
A
SER
71
n
39
SER
71
A
PRO
72
n
40
PRO
72
A
SER
73
n
41
SER
73
A
ASN
74
n
42
ASN
74
A
GLN
75
n
43
GLN
75
A
THR
76
n
44
THR
76
A
ASP
77
n
45
ASP
77
A
LYS
78
n
46
LYS
78
A
LEU
79
n
47
LEU
79
A
ALA
80
n
48
ALA
80
A
ALA
81
n
49
ALA
81
A
PHE
82
n
50
PHE
82
A
PRO
83
n
51
PRO
83
A
GLU
84
n
52
GLU
84
A
ASP
85
n
53
ASP
85
A
ARG
86
n
54
ARG
86
A
SER
87
n
55
SER
87
A
GLN
88
n
56
GLN
88
A
PRO
89
n
57
PRO
89
A
GLY
90
n
58
GLY
90
A
GLN
91
n
59
GLN
91
A
ASP
92
n
60
ASP
92
A
SER
93
n
61
SER
93
A
ARG
94
n
62
ARG
94
A
PHE
95
n
63
PHE
95
A
ARG
96
n
64
ARG
96
A
VAL
97
n
65
VAL
97
A
THR
98
n
66
THR
98
A
GLN
99
n
67
GLN
99
A
LEU
100
n
68
LEU
100
A
PRO
101
n
69
PRO
101
A
ASN
102
n
70
ASN
102
A
GLY
103
n
71
GLY
103
A
ARG
104
n
72
ARG
104
A
ASP
105
n
73
ASP
105
A
PHE
106
n
74
PHE
106
A
HIS
107
n
75
HIS
107
A
MET
108
n
76
MET
108
A
SER
109
n
77
SER
109
A
VAL
110
n
78
VAL
110
A
VAL
111
n
79
VAL
111
A
ARG
112
n
80
ARG
112
A
ALA
113
n
81
ALA
113
A
ARG
114
n
82
ARG
114
A
ARG
115
n
83
ARG
115
A
ASN
116
n
84
ASN
116
A
ASP
117
n
85
ASP
117
A
SER
118
n
86
SER
118
A
GLY
119
n
87
GLY
119
A
THR
120
n
88
THR
120
A
TYR
121
n
89
TYR
121
A
LEU
122
n
90
LEU
122
A
CYS
123
n
91
CYS
123
A
GLY
124
n
92
GLY
124
A
ALA
125
n
93
ALA
125
A
ILE
126
n
94
ILE
126
A
SER
127
n
95
SER
127
A
LEU
128
n
96
LEU
128
A
ALA
129
n
97
ALA
129
A
PRO
130
n
98
PRO
130
A
LYS
131
n
99
LYS
131
A
ALA
132
n
100
ALA
132
A
GLN
133
n
101
GLN
133
A
ILE
134
n
102
ILE
134
A
LYS
135
n
103
LYS
135
A
GLU
136
n
104
GLU
136
A
SER
137
n
105
SER
137
A
LEU
138
n
106
LEU
138
A
ARG
139
n
107
ARG
139
A
ALA
140
n
108
ALA
140
A
GLU
141
n
109
GLU
141
A
LEU
142
n
110
LEU
142
A
ARG
143
n
111
ARG
143
A
VAL
144
n
112
VAL
144
A
THR
145
n
113
THR
145
A
GLU
146
n
114
GLU
146
A
ARG
147
n
115
ARG
147
A
ARG
148
n
116
ARG
148
A
ALA
149
n
117
ALA
149
A
GLU
150
n
118
GLU
150
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
SER
38
A
N
SER
6
A
O
THR
53
A
O
THR
21
A
N
ALA
50
A
N
ALA
18
A
O
VAL
110
A
O
VAL
78
A
O
HIS
107
A
O
HIS
75
A
N
THR
98
A
N
THR
66
A
N
VAL
44
A
N
VAL
12
A
O
THR
145
A
O
THR
113
A
O
LEU
142
A
O
LEU
110
A
N
GLY
119
A
N
GLY
87
A
O
ILE
126
A
O
ILE
94
A
N
VAL
64
A
N
VAL
32
A
N
TRP
67
A
N
TRP
35
A
O
LEU
79
A
O
LEU
47
35
A
ARG
94
0.093
SIDE CHAIN
1
3.12
0.50
120.30
123.42
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
2
3.02
0.50
120.30
123.32
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
2
3.84
0.50
120.30
124.14
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
96
96
96
N
4
3.03
0.50
120.30
123.33
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
6
3.10
0.50
120.30
123.40
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
114
114
114
N
7
3.36
0.50
120.30
123.66
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
96
96
96
N
7
-3.28
0.50
120.30
117.02
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
115
115
115
N
8
3.08
0.50
120.30
123.38
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
8
3.55
0.50
120.30
123.85
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
115
115
115
N
9
3.24
0.50
120.30
123.54
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
148
148
148
N
11
3.30
0.50
120.30
123.60
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
11
3.22
0.50
120.30
123.52
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
12
3.26
0.50
120.30
123.56
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
96
96
96
N
12
3.27
0.50
120.30
123.57
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
139
139
139
N
15
3.05
0.50
120.30
123.35
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
16
3.88
0.50
120.30
124.18
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
17
3.27
0.50
120.30
123.57
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
17
3.41
0.50
120.30
123.71
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
139
139
139
N
18
-3.13
0.50
120.30
117.17
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
115
115
115
N
19
3.50
0.50
120.30
123.80
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
20
3.08
0.50
120.30
123.38
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
21
3.30
0.50
120.30
123.60
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
148
148
148
N
22
4.01
0.50
120.30
124.31
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
22
3.55
0.50
120.30
123.85
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
147
147
147
N
23
3.07
0.50
120.30
123.37
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
23
3.44
0.50
120.30
123.74
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
148
148
148
N
25
3.22
0.50
120.30
123.52
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
26
3.04
0.50
120.30
123.34
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
114
114
114
N
27
3.27
0.50
120.30
123.57
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
139
139
139
N
27
3.16
0.50
120.30
123.46
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
147
147
147
N
28
3.46
0.50
120.30
123.76
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
29
3.88
0.50
120.30
124.18
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
115
115
115
N
29
-3.11
0.50
120.30
117.19
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
115
115
115
N
29
3.02
0.50
120.30
123.32
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
148
148
148
N
30
3.26
0.50
120.30
123.56
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
148
148
148
N
31
3.01
0.50
120.30
123.31
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
32
3.06
0.50
120.30
123.36
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
33
3.01
0.50
120.30
123.31
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
33
3.43
0.50
120.30
123.73
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
94
94
94
N
33
-3.16
0.50
120.30
117.14
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
114
114
114
N
34
3.08
0.50
120.30
123.38
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
86
86
86
N
35
3.76
0.50
120.30
124.06
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
139
139
139
N
1
A
GLU
84
-68.32
94.55
1
A
SER
87
70.02
-60.96
1
A
ARG
112
62.60
72.29
2
A
SER
60
-81.90
39.66
2
A
ARG
104
-154.50
73.61
3
A
ASP
85
-85.11
33.46
3
A
ASP
92
-142.94
55.40
3
A
ARG
94
80.63
-34.13
3
A
ASP
105
174.12
142.20
3
A
ARG
112
57.49
77.09
4
A
ASN
74
75.60
36.79
4
A
SER
87
70.29
-61.08
4
A
ARG
104
-154.50
73.64
4
A
ARG
112
53.63
73.43
4
A
LEU
138
68.94
173.88
5
A
PRO
35
-58.66
109.18
6
A
GLU
84
-68.78
94.51
6
A
SER
87
68.05
-25.16
6
A
ASP
105
179.76
136.91
7
A
ARG
86
-57.66
-7.87
7
A
ARG
104
-154.41
73.51
7
A
ASP
105
-174.64
147.43
8
A
ASN
74
70.53
45.75
8
A
SER
87
81.90
-42.45
8
A
ARG
104
-154.49
73.28
9
A
GLU
61
-78.20
-70.74
9
A
ARG
104
-152.44
73.54
9
A
ARG
112
48.37
76.92
10
A
SER
62
128.96
165.17
10
A
ARG
104
-154.58
73.61
10
A
ASP
105
-178.76
148.37
10
A
ARG
112
55.34
84.96
11
A
ASP
85
-152.78
38.93
11
A
ARG
104
-154.63
73.65
11
A
ARG
112
49.30
72.61
12
A
SER
62
84.76
166.84
12
A
SER
87
59.78
19.01
12
A
GLN
91
56.84
-101.11
12
A
ARG
94
-153.63
-18.01
12
A
ARG
104
-154.57
73.52
12
A
ASP
105
-171.47
145.41
12
A
LEU
138
66.84
-178.55
13
A
ARG
104
-154.58
73.59
14
A
GLU
61
71.40
-67.07
14
A
SER
62
176.30
160.49
14
A
ASP
105
-178.78
140.68
15
A
THR
59
-104.78
-169.54
15
A
ASN
74
71.31
46.07
15
A
SER
87
75.01
-54.65
15
A
ARG
94
77.77
-27.05
15
A
ASP
105
-178.37
146.00
16
A
ARG
86
-66.09
-77.68
16
A
SER
87
67.44
-59.72
16
A
ASP
105
-174.89
141.72
16
A
ARG
112
51.08
70.42
17
A
SER
73
-76.97
21.31
17
A
ASP
85
-161.17
41.43
17
A
SER
87
78.75
-3.89
17
A
ARG
104
-154.60
73.76
18
A
THR
36
-171.76
147.72
18
A
SER
87
65.33
-26.21
18
A
ASP
105
178.99
136.57
19
A
GLU
84
-62.68
97.76
19
A
ASP
85
-77.99
44.19
19
A
ASP
105
-174.22
137.68
20
A
SER
87
69.71
-35.28
21
A
SER
87
69.22
-47.69
21
A
PRO
89
-62.03
-172.82
22
A
PHE
37
-161.85
111.99
22
A
ASP
105
-170.15
141.60
23
A
GLN
91
70.11
-40.62
23
A
ARG
104
-154.57
73.69
23
A
ASP
105
-173.73
148.67
24
A
ASP
105
-177.64
140.82
25
A
ARG
86
-101.73
-77.62
25
A
SER
87
59.36
-58.56
25
A
ARG
104
-154.59
73.66
25
A
ASP
105
-173.80
147.53
25
A
LEU
138
-55.65
106.96
27
A
SER
62
82.07
117.72
27
A
SER
87
66.35
-61.18
27
A
ARG
112
59.39
73.88
28
A
GLU
61
77.87
-30.87
28
A
ARG
94
62.43
-35.39
28
A
ARG
112
54.97
70.39
29
A
ASP
105
-175.47
143.94
29
A
ARG
112
54.75
71.33
30
A
GLU
61
71.92
-46.81
30
A
GLU
84
-68.35
94.45
30
A
SER
87
98.49
154.70
30
A
GLN
91
-92.14
-143.79
31
A
ASP
85
-93.05
35.43
31
A
ARG
104
-154.50
73.53
31
A
ASP
105
-170.39
136.97
31
A
SER
137
-108.33
-166.13
32
A
ARG
86
-56.88
-6.07
32
A
ARG
104
-154.48
73.65
33
A
GLU
61
-93.50
-79.24
33
A
ARG
104
-111.53
73.65
33
A
ASP
105
175.36
141.30
34
A
GLU
61
70.29
-0.76
34
A
SER
87
66.44
-45.12
34
A
ARG
104
-154.51
73.53
34
A
ARG
112
39.70
61.16
35
A
SER
60
69.36
-30.95
35
A
GLN
91
73.18
-52.58
35
A
ARG
104
-154.62
73.71
35
A
ASP
105
-178.02
143.02
Programmed cell death protein 1
closest to the average, model 11
Human programmed cell death 1 receptor
1
N
N
A
ARG
114
A
ARG
82
HELX_P
A
SER
118
A
SER
86
5
1
5
disulf
2.048
A
CYS
54
A
SG
CYS
22
1_555
A
CYS
123
A
SG
CYS
91
1_555
APOPTOSIS
PD-1, APOPTOSIS
A
SER
38
A
SER
6
1
A
PRO
39
A
PRO
7
-5.63
A
PHE
82
A
PHE
50
1
A
PRO
83
A
PRO
51
-12.43
A
SER
38
A
SER
6
2
A
PRO
39
A
PRO
7
-2.12
A
PHE
82
A
PHE
50
2
A
PRO
83
A
PRO
51
-8.57
A
SER
38
A
SER
6
3
A
PRO
39
A
PRO
7
-2.91
A
PHE
82
A
PHE
50
3
A
PRO
83
A
PRO
51
-7.29
A
SER
38
A
SER
6
4
A
PRO
39
A
PRO
7
-13.00
A
PHE
82
A
PHE
50
4
A
PRO
83
A
PRO
51
-10.65
A
SER
38
A
SER
6
5
A
PRO
39
A
PRO
7
-4.94
A
PHE
82
A
PHE
50
5
A
PRO
83
A
PRO
51
-7.03
A
SER
38
A
SER
6
6
A
PRO
39
A
PRO
7
-4.45
A
PHE
82
A
PHE
50
6
A
PRO
83
A
PRO
51
-8.55
A
SER
38
A
SER
6
7
A
PRO
39
A
PRO
7
-3.14
A
PHE
82
A
PHE
50
7
A
PRO
83
A
PRO
51
-10.75
A
SER
38
A
SER
6
8
A
PRO
39
A
PRO
7
-5.18
A
PHE
82
A
PHE
50
8
A
PRO
83
A
PRO
51
-12.46
A
SER
38
A
SER
6
9
A
PRO
39
A
PRO
7
-6.09
A
PHE
82
A
PHE
50
9
A
PRO
83
A
PRO
51
-9.40
A
SER
38
A
SER
6
10
A
PRO
39
A
PRO
7
-11.96
A
PHE
82
A
PHE
50
10
A
PRO
83
A
PRO
51
-11.34
A
SER
38
A
SER
6
11
A
PRO
39
A
PRO
7
-11.53
A
PHE
82
A
PHE
50
11
A
PRO
83
A
PRO
51
-10.68
A
SER
38
A
SER
6
12
A
PRO
39
A
PRO
7
-9.38
A
PHE
82
A
PHE
50
12
A
PRO
83
A
PRO
51
-8.80
A
SER
38
A
SER
6
13
A
PRO
39
A
PRO
7
-4.75
A
PHE
82
A
PHE
50
13
A
PRO
83
A
PRO
51
-6.39
A
SER
38
A
SER
6
14
A
PRO
39
A
PRO
7
-4.45
A
PHE
82
A
PHE
50
14
A
PRO
83
A
PRO
51
-5.47
A
SER
38
A
SER
6
15
A
PRO
39
A
PRO
7
-7.85
A
PHE
82
A
PHE
50
15
A
PRO
83
A
PRO
51
-7.66
A
SER
38
A
SER
6
16
A
PRO
39
A
PRO
7
-7.51
A
PHE
82
A
PHE
50
16
A
PRO
83
A
PRO
51
-8.31
A
SER
38
A
SER
6
17
A
PRO
39
A
PRO
7
-10.41
A
PHE
82
A
PHE
50
17
A
PRO
83
A
PRO
51
-10.73
A
SER
38
A
SER
6
18
A
PRO
39
A
PRO
7
-9.35
A
PHE
82
A
PHE
50
18
A
PRO
83
A
PRO
51
-11.57
A
SER
38
A
SER
6
19
A
PRO
39
A
PRO
7
-5.38
A
PHE
82
A
PHE
50
19
A
PRO
83
A
PRO
51
-9.36
A
SER
38
A
SER
6
20
A
PRO
39
A
PRO
7
-7.79
A
PHE
82
A
PHE
50
20
A
PRO
83
A
PRO
51
-8.65
A
SER
38
A
SER
6
21
A
PRO
39
A
PRO
7
-6.73
A
PHE
82
A
PHE
50
21
A
PRO
83
A
PRO
51
-14.32
A
SER
38
A
SER
6
22
A
PRO
39
A
PRO
7
-10.07
A
PHE
82
A
PHE
50
22
A
PRO
83
A
PRO
51
-11.13
A
SER
38
A
SER
6
23
A
PRO
39
A
PRO
7
-7.42
A
PHE
82
A
PHE
50
23
A
PRO
83
A
PRO
51
2.75
A
SER
38
A
SER
6
24
A
PRO
39
A
PRO
7
-2.46
A
PHE
82
A
PHE
50
24
A
PRO
83
A
PRO
51
-12.95
A
SER
38
A
SER
6
25
A
PRO
39
A
PRO
7
-8.65
A
PHE
82
A
PHE
50
25
A
PRO
83
A
PRO
51
-5.57
A
SER
38
A
SER
6
26
A
PRO
39
A
PRO
7
-6.40
A
PHE
82
A
PHE
50
26
A
PRO
83
A
PRO
51
-6.30
A
SER
38
A
SER
6
27
A
PRO
39
A
PRO
7
-10.07
A
PHE
82
A
PHE
50
27
A
PRO
83
A
PRO
51
-10.18
A
SER
38
A
SER
6
28
A
PRO
39
A
PRO
7
-6.56
A
PHE
82
A
PHE
50
28
A
PRO
83
A
PRO
51
-3.93
A
SER
38
A
SER
6
29
A
PRO
39
A
PRO
7
-8.99
A
PHE
82
A
PHE
50
29
A
PRO
83
A
PRO
51
-5.80
A
SER
38
A
SER
6
30
A
PRO
39
A
PRO
7
-4.26
A
PHE
82
A
PHE
50
30
A
PRO
83
A
PRO
51
-11.66
A
SER
38
A
SER
6
31
A
PRO
39
A
PRO
7
-6.43
A
PHE
82
A
PHE
50
31
A
PRO
83
A
PRO
51
-4.25
A
SER
38
A
SER
6
32
A
PRO
39
A
PRO
7
-2.53
A
PHE
82
A
PHE
50
32
A
PRO
83
A
PRO
51
-9.32
A
SER
38
A
SER
6
33
A
PRO
39
A
PRO
7
-5.17
A
PHE
82
A
PHE
50
33
A
PRO
83
A
PRO
51
-4.79
A
SER
38
A
SER
6
34
A
PRO
39
A
PRO
7
-11.38
A
PHE
82
A
PHE
50
34
A
PRO
83
A
PRO
51
-12.04
A
SER
38
A
SER
6
35
A
PRO
39
A
PRO
7
-7.95
A
PHE
82
A
PHE
50
35
A
PRO
83
A
PRO
51
-9.03
PDCD1_HUMAN
UNP
1
34
Q15116
PPTFSPALLVVTEGDNATFTCSFSNTSESFVLNWYRMSPSNQTDKLAAFPEDRSQPGQDCRFRVTQLPNGRDFHMSVVRA
RRNDSGTYLCGAISLAPKAQIKESLRAELRVTERRAE
34
150
2M2D
34
150
Q15116
A
1
2
118
1
EXPRESSION TAG
MET
33
2M2D
A
Q15116
UNP
1
1
CYS
CONFLICT
SER
93
2M2D
A
Q15116
UNP
93
61
4
5
anti-parallel
anti-parallel
anti-parallel
parallel
anti-parallel
anti-parallel
anti-parallel
A
THR
36
A
THR
4
A
SER
38
A
SER
6
A
ALA
50
A
ALA
18
A
SER
55
A
SER
23
A
PHE
106
A
PHE
74
A
VAL
110
A
VAL
78
A
PHE
95
A
PHE
63
A
GLN
99
A
GLN
67
A
LEU
41
A
LEU
9
A
THR
45
A
THR
13
A
LYS
135
A
LYS
103
A
THR
145
A
THR
113
A
GLY
119
A
GLY
87
A
SER
127
A
SER
95
A
PHE
63
A
PHE
31
A
MET
70
A
MET
38
A
THR
76
A
THR
44
A
PHE
82
A
PHE
50